Endophytes are regarded with immense potentials in terms of plant growth promoting (PGP) elicitors and mimicking secondary metabolites of medicinal importance. Here in the present study, we explored
Bacopa monnieri
plants to isolate, identify fungal endophytes with PGP elicitation potentials, and investigate secretion of secondary metabolites such as bacoside and withanolide content under in vitro conditions. Three fungal endophytes isolated (out of 40 saponin producing isolates) from leaves of
B. monnieri
were examined for in vitro biosynthesis of bacosides. On morphological, biochemical, and molecular identification (ITS gene sequencing), the isolated strains SUBL33, SUBL51, and SUBL206 were identified as
Nigrospora oryzae
(MH071153),
Alternaria alternata
(MH071155), and
Aspergillus terreus
(MH071154) respectively. Among these strains, SUBL33 produced highest quantity of Bacoside A
3
(4093 μg mL
−1
), Jujubogenin isomer of Bacopasaponin C (65,339 μg mL
−1
), and Bacopasaponin C (1325 μg mL
−1
) while Bacopaside II (13,030 μg mL
−1
) was produced by SUBL51 maximally. Moreover, these aforementioned strains also produced detectable concentration of withanolides—Withaferrin A, Withanolide A (480 μg mL
−1
), and Withanolide B (1024 μg mL
−1
) respectively. However, Withanolide A was not detected in the secondary metabolites of strain SUBL51. To best of our knowledge, the present study is first reports of
Nigrospora oryzae
as an endophyte in
B. monnieri
with potentials of biosynthesis of economically important phytomolecules under in vitro conditions.
Supplementary Information
The online version contains supplementary material available at 10.1007/s42770-021-00586-0.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.